Eudaimonia Partners, LLC Astrazeneca PLC Transaction History

Eudaimonia Partners, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 24, 2023	SELL	$64.85 - $71.7 $1,815 - $2,007	-28 Reduced 0.88%	3,151 $213,000
Q2 2023 Jul 19, 2023	SELL	$69.91 - $75.81 $23,629 - $25,623	-338 Reduced 9.61%	3,179 $227,000
Q1 2023 Apr 25, 2023	BUY	$63.15 - $71.6 $14,587 - $16,539	231 Added 7.03%	3,517 $244,000
Q4 2022 Jan 24, 2023	BUY	$54.21 - $70.44 $178,134 - $231,465	3,286 New	3,286 $0
Q2 2022 Aug 09, 2022	BUY	$59.26 - $71.14 $78,697 - $94,473	1,328 Added 9.83%	14,835 $980,000
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $51,819 - $62,421	-930 Reduced 6.44%	13,507 $896,000
Q3 2021 Oct 25, 2021	BUY	$55.56 - $60.79 $52,226 - $57,142	940 Added 6.96%	14,437 $867,000
Q2 2021 Aug 13, 2021	SELL	$48.42 - $60.18 $56,941 - $70,771	-1,176 Reduced 8.01%	13,497 $808,000
Q1 2021 May 17, 2021	SELL	$47.16 - $54.44 $14,478 - $16,713	-307 Reduced 2.05%	14,673 $729,000
Q4 2020 Feb 18, 2021	BUY	$48.52 - $58.02 $46,336 - $55,409	955 Added 6.81%	14,980 $749,000
Q3 2020 Nov 23, 2020	BUY	$53.07 - $61.1 $709,811 - $817,212	13,375 Added 2057.69%	14,025 $769,000
Q3 2020 Nov 16, 2020	SELL	$53.07 - $61.1 $452,952 - $521,488	-8,535 Reduced 92.92%	650 $67,000
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $56,504 - $72,511	1,311 Added 16.65%	9,185 $486,000
Q1 2020 May 05, 2020	BUY	$37.79 - $51.33 $188,950 - $256,650	5,000 Added 173.97%	7,874 $352,000
Q4 2019 May 05, 2020	BUY	$42.46 - $50.46 $122,030 - $145,022	2,874 New	2,874 $143,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Eudaimonia Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Eudaimonia Partners, LLC with notifications on news.